Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Biomedical Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 2049-9434 Online ISSN: 2049-9442
Journal Cover
February-2017 Volume 6 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February-2017 Volume 6 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Review

Protein kinase CK2 in development and differentiation (Review)

  • Authors:
    • Claudia Götz
    • Mathias Montenarh
  • View Affiliations / Copyright

    Affiliations: Department of Medical Biochemistry and Molecular Biology, Saarland University, D-66424 Homburg, Germany
  • Pages: 127-133
    |
    Published online on: December 19, 2016
       https://doi.org/10.3892/br.2016.829
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Among the human kinomes, protein kinase CK2 (formerly termed casein kinase II) is considered to be essential, as it is implicated in the regulation of various cellular processes. Experiments with pharmacological inhibitors of the kinase activity of CK2 provide evidence that CK2 is essential for development and differentiation. Therefore, the present review addresses the role of CK2 during embryogenesis, neuronal, adipogenic, osteogenic and myogenic differentiation in established model cell lines, and in embryonic, neural and mesenchymal stem cells. CK2 kinase activity appears to be essential in the early stages of differentiation, as CK2 inhibition at early time points generally prevents differentiation. In addition, the present review reports on target proteins of CK2 in embryogenesis and differentiation.
View Figures
View References

1 

Manning G, Whyte DB, Martinez R, Hunter T and Sudarsanam S: The protein kinase complement of the human genome. Science. 298:1912–1934. 2002. View Article : Google Scholar : PubMed/NCBI

2 

Hunter T: A thousand and one protein kinases. Cell. 50:823–829. 1987. View Article : Google Scholar : PubMed/NCBI

3 

Cozza G, Meggio F and Moro S: The dark side of protein kinase CK2 inhibition. Curr Med Chem. 18:2867–2884. 2011. View Article : Google Scholar : PubMed/NCBI

4 

Wang G, Ahmad KA, Unger G, Slaton JW and Ahmed K: CK2 signaling in androgen-dependent and -independent prostate cancer. J Cell Biochem. 99:382–391. 2006. View Article : Google Scholar : PubMed/NCBI

5 

St-Denis NA and Litchfield DW: Protein kinase CK2 in health and disease: From birth to death: the role of protein kinase CK2 in the regulation of cell proliferation and survival. Cell Mol Life Sci. 66:1817–1829. 2009. View Article : Google Scholar : PubMed/NCBI

6 

Ruzzene M and Pinna LA: Addiction to protein kinase CK2: A common denominator of diverse cancer cells? Biochim Biophys Acta. 1804:499–504. 2010. View Article : Google Scholar : PubMed/NCBI

7 

Trembley JH, Wang G, Unger G, Slaton J and Ahmed K: Protein kinase CK2 in health and disease: CK2: a key player in cancer biology. Cell Mol Life Sci. 66:1858–1867. 2009. View Article : Google Scholar : PubMed/NCBI

8 

Ahmad KA, Wang G, Unger G, Slaton J and Ahmed K: Protein kinase CK2 - a key suppressor of apoptosis. Adv Enzyme Regul. 48:179–187. 2008. View Article : Google Scholar : PubMed/NCBI

9 

Montenarh M: Protein kinase CK2 and angiogenesis. Adv Clin Exp Med. 23:153–158. 2014. View Article : Google Scholar : PubMed/NCBI

10 

Montenarh M: Protein kinase CK2 in DNA damage and repair. Transl Cancer Res. 5:49–63. 2016.

11 

Götz C and Montenarh M: Protein kinase CK2 in the ER stress response. Adv Biol Chem 3A. 1–5. 2013. View Article : Google Scholar

12 

Al Quobaili F and Montenarh M: CK2 and the regulation of the carbohydrate metabolism. Metabolism. 61:1512–1517. 2012. View Article : Google Scholar : PubMed/NCBI

13 

Blanquet PR: Casein kinase 2 as a potentially important enzyme in the nervous system. Prog Neurobiol. 60:211–246. 2000. View Article : Google Scholar : PubMed/NCBI

14 

Faust M and Montenarh M: Subcellular localization of protein kinase CK2. A key to its function? Cell Tissue Res. 301:329–340. 2000. View Article : Google Scholar : PubMed/NCBI

15 

Raaf J, Brunstein E, Issinger OG and Niefind K: The interaction of CK2alpha and CK2beta, the subunits of protein kinase CK2, requires CK2beta in a preformed conformation and is enthalpically driven. Protein Sci. 17:2180–2186. 2008. View Article : Google Scholar : PubMed/NCBI

16 

Meggio F, Boldyreff BS, Marin O, Pinna LA and Issinger OG: CK2: Role of the b- subunit on the stability and specificity of the recombinant reconstituted holoenzyme. Eur J Biochem. 204:293–297. 1992. View Article : Google Scholar : PubMed/NCBI

17 

Meggio F, Boldyreff B, Marin O, Marchiori F, Perich JW, Issinger OG and Pinna LA: The effect of polylysine on casein-kinase-2 activity is influenced by both the structure of the protein/peptide substrates and the subunit composition of the enzyme. Eur J Biochem. 205:939–945. 1992. View Article : Google Scholar : PubMed/NCBI

18 

Boldyreff B, Meggio F, Pinna LA and Issinger OG: Casein kinase-2 structure-function relationship: Creation of a set of mutants of the beta subunit that variably surrogate the wildtype beta subunit function. Biochem Biophys Res Commun. 188:228–234. 1992. View Article : Google Scholar : PubMed/NCBI

19 

Rodriguez FA, Contreras C, BolanosGarcia V and Allende JE: Protein kinase CK2 as an ectokinase: The role of the regulatory CK2beta subunit. Proc Natl Acad Sci USA. 105:5693–5698. 2008. View Article : Google Scholar : PubMed/NCBI

20 

Glover CV: A filamentous form of Drosophila casein kinase II. J Biol Chem. 261:14349–14354. 1986.PubMed/NCBI

21 

Mamrack MD: Stimulation of enzymatic activity in filament preparations of casein kinase II by polylysine, melittin, and spermine. Mol Cell Biochem. 85:147–157. 1989. View Article : Google Scholar : PubMed/NCBI

22 

Valero E, De Bonis S, Filhol O, Wade RH, Langowski J, Chambaz EM and Cochet C: Quaternary structure of casein kinase 2. Characterization of multiple oligomeric states and relation with its catalytic activity. J Biol Chem. 270:8345–8352. 1995. View Article : Google Scholar : PubMed/NCBI

23 

Valero E, Chambaz EM and Cochet C: Modulation of the protein kinase CK2 activity by a synthetic peptide corresponding to the N-terminus of its beta regulatory subunit. Biochem Biophys Res Commun. 232:178–182. 1997. View Article : Google Scholar : PubMed/NCBI

24 

Niefind K and Issinger OG: Primary and secondary interactions between CK2alpha and CK2beta lead to ring-like structures in the crystals of the CK2 holoenzyme. Mol Cell Biochem. 274:3–14. 2005. View Article : Google Scholar : PubMed/NCBI

25 

Landesman-Bollag E, Belkina A, Hovey B, Connors E, Cox C and Seldin DC: Developmental and growth defects in mice with combined deficiency of CK2 catalytic genes. Mol Cell Biochem. 356:227–231. 2011. View Article : Google Scholar : PubMed/NCBI

26 

Filhol O, Nueda A, Martel V, GerberScokaert D, Benitez MJ, Souchier C, Saoudi Y and Cochet C: Live-cell fluorescence imaging reveals the dynamics of protein kinase CK2 individual subunits. Mol Cell Biol. 23:975–987. 2003. View Article : Google Scholar : PubMed/NCBI

27 

Filhol O, Martiel JL and Cochet C: Protein kinase CK2: A new view of an old molecular complex. EMBO Rep. 5:351–355. 2004. View Article : Google Scholar : PubMed/NCBI

28 

Bibby AC and Litchfield DW: The multiple personalities of the regulatory subunit of protein kinase CK2: CK2 dependent and CK2 independent roles reveal a secret identity for CK2beta. Int J Biol Sci. 1:67–79. 2005. View Article : Google Scholar : PubMed/NCBI

29 

Bolanos-Garcia VM, FernandezRecio J, Allende JE and Blundell TL: Identifying interaction motifs in CK2beta - a ubiquitous kinase regulatory subunit. Trends Biochem Sci. 31:654–661. 2006. View Article : Google Scholar : PubMed/NCBI

30 

Montenarh M: Cellular regulators of protein kinase CK2. Cell Tissue Res. 342:139–146. 2010. View Article : Google Scholar : PubMed/NCBI

31 

Lou DY, Dominguez I, Toselli P, LandesmanBollag E, O'Brien C and Seldin DC: The alpha catalytic subunit of protein kinase CK2 is required for mouse embryonic development. Mol Cell Biol. 28:131–139. 2008. View Article : Google Scholar : PubMed/NCBI

32 

Dominguez I, Degano IR, Chea K, Cha J, Toselli P and Seldin DC: CK2α is essential for embryonic morphogenesis. Mol Cell Biochem. 356:209–216. 2011. View Article : Google Scholar : PubMed/NCBI

33 

Buchou T, Vernet M, Blond O, Jensen HH, Pointu H, Olsen BB, Cochet C, Issinger OG and Boldyreff B: Disruption of the regulatory beta subunit of protein kinase CK2 in mice leads to a cell-autonomous defect and early embryonic lethality. Mol Cell Biol. 23:908–915. 2003. View Article : Google Scholar : PubMed/NCBI

34 

Alvarez LM, RevueltaCervantes J and Dominguez I: CK2 in embryonic development. in Protein kinase CK2Pinna LA: John Wiley & Sons, Inc.; Ames, Chichester, Oxford: pp. 129–168. 2013

35 

Schneider HR, Reichert GH and Issinger OG: Enhanced casein kinase II activity during mouse embryogenesis. Identification of a 110-kDa phosphoprotein as the major phosphorylation product in mouse embryos and Krebs II mouse ascites tumor cells. Eur J Biochem. 161:733–738. 1986. View Article : Google Scholar : PubMed/NCBI

36 

Perez M, Grande J and Itarte E: Developmental changes in rat hepatic casein kinases 1 and 2. Eur J Biochem. 170:493–498. 1987. View Article : Google Scholar : PubMed/NCBI

37 

Maridor G, Park W, Krek W and Nigg EA: Casein kinase II. cDNA sequences, developmental expression, and tissue distribution of mRNAs for alpha, alpha', and beta subunits of the chicken enzyme. J Biol Chem. 266:2362–2368. 1991.PubMed/NCBI

38 

Mestres P, Boldyreff B, Ebensperger C, Hameister H and Issinger OG: Expression of casein kinase 2 during mouse embryogenesis. Acta Anat (Basel). 149:13–20. 1994. View Article : Google Scholar : PubMed/NCBI

39 

Wirkner U and Pyerin W: CK2alpha loci in the human genome: Structure and transcriptional activity. Mol Cell Biochem. 191:59–64. 1999. View Article : Google Scholar : PubMed/NCBI

40 

Escalier D, Silvius D and Xu X: Spermatogenesis of mice lacking CK2alpha': Failure of germ cell survival and characteristic modifications of the spermatid nucleus. Mol Reprod Dev. 66:190–201. 2003. View Article : Google Scholar : PubMed/NCBI

41 

Blond O, Jensen HH, Buchou T, Cochet C, Issinger OG and Boldyreff B: Knocking out the regulatory beta subunit of protein kinase CK2 in mice: Gene dosage effects in ES cells and embryos. Mol Cell Biochem. 274:31–37. 2005. View Article : Google Scholar : PubMed/NCBI

42 

Huillard E, Ziercher L, Blond O, Wong M, Deloulme JC, Souchelnytskyi S, Baudier J, Cochet C and Buchou T: Disruption of CK2beta in embryonic neural stem cells compromises proliferation and oligodendrogenesis in the mouse telencephalon. Mol Cell Biol. 30:2737–2749. 2010. View Article : Google Scholar : PubMed/NCBI

43 

Ziercher L, Filhol O, Laudet B, Prudent R, Cochet C and Buchou T: Structure-function analysis of the beta regulatory subunit of protein kinase CK2 by targeting embryonic stem cell. Mol Cell Biochem. 356:75–81. 2011. View Article : Google Scholar : PubMed/NCBI

44 

Díaz-Nido J, Mizuno K, Nawa H and Marshak DR: Regulation of protein kinase CK2 isoform expression during rat brain development. Cell Mol Biol Res. 40:581–585. 1994.PubMed/NCBI

45 

Avila J, Ulloa L, González J, Moreno F and Díaz-Nido J: Phosphorylation of microtubule-associated proteins by protein kinase CK2 in neuritogenesis. Cell Mol Biol Res. 40:573–579. 1994.PubMed/NCBI

46 

Moreno FJ, Díaz-Nido J, Jiménez JS and Avila J: Distribution of CK2, its substrate MAP1B and phosphatases in neuronal cells. Mol Cell Biochem. 191:201–205. 1999. View Article : Google Scholar : PubMed/NCBI

47 

Nuthall HN, Husain J, McLarren KW and Stifani S: Role for Hes1-induced phosphorylation in Groucho-mediated transcriptional repression. Mol Cell Biol. 22:389–399. 2002. View Article : Google Scholar : PubMed/NCBI

48 

Gratton MO, Torban E, Jasmin SB, Theriault FM, German MS and Stifani S: Hes6 promotes cortical neurogenesis and inhibits Hes1 transcription repression activity by multiple mechanisms. Mol Cell Biol. 23:6922–6935. 2003. View Article : Google Scholar : PubMed/NCBI

49 

Nuthall HN, Joachim K and Stifani S: Phosphorylation of serine 239 of Groucho/TLE1 by protein kinase CK2 is important for inhibition of neuronal differentiation. Mol Cell Biol. 24:8395–8407. 2004. View Article : Google Scholar : PubMed/NCBI

50 

Jans DA, Xiao CY and Lam MH: Nuclear targeting signal recognition: A key control point in nuclear transport? BioEssays. 22:532–544. 2000. View Article : Google Scholar : PubMed/NCBI

51 

Kuhn HG, Winkler J, Kempermann G, Thal LJ and Gage FH: Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. J Neurosci. 17:5820–5829. 1997.PubMed/NCBI

52 

Bonnet H, Filhol O, Truchet I, Brethenou P, Cochet C, Amalric F and Bouche G: Fibroblast growth factor-2 binds to the regulatory beta subunit of CK2 and directly stimulates CK2 activity toward nucleolin. J Biol Chem. 271:24781–24787. 1996. View Article : Google Scholar : PubMed/NCBI

53 

Jessberger S, Gage FH, Eisch AJ and Lagace DC: Making a neuron: Cdk5 in embryonic and adult neurogenesis. Trends Neurosci. 32:575–582. 2009. View Article : Google Scholar : PubMed/NCBI

54 

Lim ACB, Hou Z, Goh CP and Qi RZ: Protein kinase CK2 is an inhibitor of the neuronal Cdk5 kinase. J Biol Chem. 279:46668–46673. 2004. View Article : Google Scholar : PubMed/NCBI

55 

Viñals F, Reiriz J, Ambrosio S, Bartrons R, Rosa JL and Ventura F: BMP-2 decreases Mash1 stability by increasing Id1 expression. EMBO J. 23:3527–3537. 2004. View Article : Google Scholar : PubMed/NCBI

56 

Karakas E, Regan MC and Furukawa H: Emerging structural insights into the function of ionotropic glutamate receptors. Trends Biochem Sci. 40:328–337. 2015. View Article : Google Scholar : PubMed/NCBI

57 

Cull-Candy SG and Leszkiewicz DN: Role of distinct NMDA receptor subtypes at central synapses. Sci STKE. 2004:re16–re2004. 2004.PubMed/NCBI

58 

Chung HJ, Huang YH, Lau LF and Huganir RL: Regulation of the NMDA receptor complex and trafficking by activity-dependent phosphorylation of the NR2B subunit PDZ ligand. J Neurosci. 24:10248–10259. 2004. View Article : Google Scholar : PubMed/NCBI

59 

Sanz-Clemente A, Matta JA, Isaac JT and Roche KW: Casein kinase 2 regulates the NR2 subunit composition of synaptic NMDA receptors. Neuron. 67:984–996. 2010. View Article : Google Scholar : PubMed/NCBI

60 

Sommercorn J and Krebs EG: Induction of casein kinase II during differentiation of 3T3-L1 cells. J Biol Chem. 262:3839–3843. 1987.PubMed/NCBI

61 

Wilhelm N, Kostelnik K, Götz C and Montenarh M: Protein kinase CK2 is implicated in early steps of the differentiation of pre-adipocytes into adipocytes. Mol Cell Biochem. 365:37–45. 2012. View Article : Google Scholar : PubMed/NCBI

62 

Schwind L, Wilhelm N, Kartarius S, Montenarh M, Gorjup E and Götz C: Protein kinase CK2 is necessary for the adipogenic differentiation of human mesenchymal stem cells. Biochim Biophys Acta 1853 (10 Pt A). 2207–2216. 2015.

63 

Schwind L, Zimmer AD, Götz C and Montenarh M: CK2 phosphorylation of C/EBPδ regulates its transcription factor activity. Int J Biochem Cell Biol. 61:81–89. 2015. View Article : Google Scholar : PubMed/NCBI

64 

Meruvu S, Hugendubler L and Mueller E: Regulation of adipocyte differentiation by the zinc finger protein ZNF638. J Biol Chem. 286:26516–26523. 2011. View Article : Google Scholar : PubMed/NCBI

65 

Almalki SG and Agrawal DK: Key transcription factors in the differentiation of mesenchymal stem cells. Differentiation. 92:41–51. 2016. View Article : Google Scholar : PubMed/NCBI

66 

Miller PJ, Dietz KN and Hollenbach AD: Identification of serine 205 as a site of phosphorylation on Pax3 in proliferating but not differentiating primary myoblasts. Protein Sci. 17:1979–1986. 2008. View Article : Google Scholar : PubMed/NCBI

67 

Dietz KN, Miller PJ and Hollenbach AD: Phosphorylation of serine 205 by the protein kinase CK2 persists on Pax3-FOXO1, but not Pax3, throughout early myogenic differentiation. Biochemistry. 48:11786–11795. 2009. View Article : Google Scholar : PubMed/NCBI

68 

Iyengar AS, Loupe JM, Miller PJ and Hollenbach AD: Identification of CK2 as the kinase that phosphorylates Pax3 at Ser209 in early myogenic differentiation. Biochem Biophys Res Commun. 428:24–30. 2012. View Article : Google Scholar : PubMed/NCBI

69 

Johnson SE, Wang X, Hardy S, Taparowsky EJ and Konieczny SF: Casein kinase II increases the transcriptional activities of MRF4 and MyoD independently of their direct phosphorylation. Mol Cell Biol. 16:1604–1613. 1996. View Article : Google Scholar : PubMed/NCBI

70 

Winter B, Kautzner I, Issinger OG and Arnold HH: Two putative protein kinase CK2 phosphorylation sites are important for Myf-5 activity. Biol Chem. 378:1445–1456. 1997. View Article : Google Scholar : PubMed/NCBI

71 

Dick SA, Chang NC, Dumont NA, Bell RA, Putinski C, Kawabe Y, Litchfield DW, Rudnicki MA and Megeney LA: Caspase 3 cleavage of Pax7 inhibits self-renewal of satellite cells. Proc Natl Acad Sci USA. 112:E5246–E5252. 2015. View Article : Google Scholar : PubMed/NCBI

72 

Turowec JP, Duncan JS, Gloor GB and Litchfield DW: Regulation of caspase pathways by protein kinase CK2: Identification of proteins with overlapping CK2 and caspase consensus motifs. Mol Cell Biochem. 356:159–167. 2011. View Article : Google Scholar : PubMed/NCBI

73 

Kathrein KL, Lorenz R, Innes AM, Griffiths E and Winandy S: Ikaros induces quiescence and T-cell differentiation in a leukemia cell line. Mol Cell Biol. 25:1645–1654. 2005. View Article : Google Scholar : PubMed/NCBI

74 

Gómez-del Arco P, Maki K and Georgopoulos K: Phosphorylation controls Ikaros's ability to negatively regulate the G(1)-S transition. Mol Cell Biol. 24:2797–2807. 2004. View Article : Google Scholar : PubMed/NCBI

75 

Son E, Do H, Joo HM and Pyo S: Induction of alkaline phosphatase activity by L-ascorbic acid in human osteoblastic cells: A potential role for CK2 and Ikaros. Nutrition. 23:745–753. 2007. View Article : Google Scholar : PubMed/NCBI

76 

Son YH, Moon SH and Kim J: The protein kinase 2 inhibitor CX-4945 regulates osteoclast and osteoblast differentiation in vitro. Mol Cells. 36:417–423. 2013. View Article : Google Scholar : PubMed/NCBI

77 

Siddiqui-Jain A, Drygin D, Streiner N, Chua P, Pierre F, O'Brien SE, Bliesath J, Omori M, Huser N, Ho C, et al: CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy. Cancer Res. 70:10288–10298. 2010. View Article : Google Scholar : PubMed/NCBI

78 

Bragdon B, Thinakaran S, Moseychuk O, King D, Young K, Litchfield DW, Petersen NO and Nohe A: Casein kinase 2 beta-subunit is a regulator of bone morphogenetic protein 2 signaling. Biophys J. 99:897–904. 2010. View Article : Google Scholar : PubMed/NCBI

79 

Bragdon B, Thinakaran S, Moseychuk O, Gurski L, Bonor J, Price C, Wang L, Beamer WG and Nohe A: Casein kinase 2 regulates in vivo bone formation through its interaction with bone morphogenetic protein receptor type Ia. Bone. 49:944–954. 2011. View Article : Google Scholar : PubMed/NCBI

80 

Moseychuk O, Akkiraju H, Dutta J, D'Angelo A, Bragdon B, Duncan RL and Nohe A: Inhibition of CK2 binding to BMPRIa induces C2C12 differentiation into osteoblasts and adipocytes. J Cell Commun Signal. 7:265–278. 2013. View Article : Google Scholar : PubMed/NCBI

81 

Akkiraju H, Bonor J and Nohe A: CK2.1, a novel peptide, induces articular cartilage formation in vivo. J Orthop Res. Jun 17–2016.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI

82 

Akkiraju H, Bonor J, Olli K, Bowen C, Bragdon B, Coombs H, Donahue LR, Duncan R and Nohe A: Systemic injection of CK2.3, a novel peptide acting downstream of bone morphogenetic protein receptor BMPRIa, leads to increased trabecular bone mass. J Orthop Res. 33:208–215. 2015. View Article : Google Scholar : PubMed/NCBI

83 

Franceschi RT and Iyer BS: Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3-E1 cells. J Bone Miner Res. 7:235–246. 1992. View Article : Google Scholar : PubMed/NCBI

84 

Georgopoulos K, Winandy S and Avitahl N: The role of the Ikaros gene in lymphocyte development and homeostasis. Annu Rev Immunol. 15:155–176. 1997. View Article : Google Scholar : PubMed/NCBI

85 

Dovat S, Song C, Payne KJ and Li Z: Ikaros, CK2 kinase, and the road to leukemia. Mol Cell Biochem. 356:201–207. 2011. View Article : Google Scholar : PubMed/NCBI

86 

Song C, Li Z, Erbe AK, Savic A and Dovat S: Regulation of Ikaros function by casein kinase 2 and protein phosphatase 1. World J Biol Chem. 2:126–131. 2011. View Article : Google Scholar : PubMed/NCBI

87 

Channavajhala P and Seldin DC: Functional interaction of protein kinase CK2 and c-Myc in lymphomagenesis. Oncogene. 21:5280–5288. 2002. View Article : Google Scholar : PubMed/NCBI

88 

Kelliher MA, Seldin DC and Leder P: Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha. EMBO J. 15:5160–5166. 1996.PubMed/NCBI

89 

Landesman-Bollag E, Channavajhala PL, Cardiff RD and Seldin DC: p53 deficiency and misexpression of protein kinase CK2alpha collaborate in the development of thymic lymphomas in mice. Oncogene. 16:2965–2974. 1998. View Article : Google Scholar : PubMed/NCBI

90 

Seldin DC and Leder P: Casein kinase II alpha transgene-induced murine lymphoma: Relation to theileriosis in cattle. Science. 267:894–897. 1995. View Article : Google Scholar : PubMed/NCBI

91 

Avitahl N, Winandy S, Friedrich C, Jones B, Ge Y and Georgopoulos K: Ikaros sets thresholds for T cell activation and regulates chromosome propagation. Immunity. 10:333–343. 1999. View Article : Google Scholar : PubMed/NCBI

92 

Ulges A, Klein M, Reuter S, Gerlitzki B, Hoffmann M, Grebe N, Staudt V, Stergiou N, Bohn T, Brühl TJ, et al: Protein kinase CK2 enables regulatory T cells to suppress excessive TH2 responses in vivo. Nat Immunol. 16:267–275. 2015. View Article : Google Scholar : PubMed/NCBI

93 

Ulges A, Witsch EJ, Pramanik G, Klein M, Birkner K, Bühler U, Wasser B, Luessi F, Stergiou N, Dietzen S, et al: Protein kinase CK2 governs the molecular decision between encephalitogenic TH17 cell and Treg cell development. Proc Natl Acad Sci USA. 113:10145–10150. 2016. View Article : Google Scholar : PubMed/NCBI

94 

Intemann J, Saidu NEB, Schwind L and Montenarh M: ER stress signaling in ARPE-19 cells after inhibition of protein kinase CK2 by CX-4945. Cell Signal. 26:1567–1575. 2014. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Götz C and Montenarh M: Protein kinase CK2 in development and differentiation (Review). Biomed Rep 6: 127-133, 2017.
APA
Götz, C., & Montenarh, M. (2017). Protein kinase CK2 in development and differentiation (Review). Biomedical Reports, 6, 127-133. https://doi.org/10.3892/br.2016.829
MLA
Götz, C., Montenarh, M."Protein kinase CK2 in development and differentiation (Review)". Biomedical Reports 6.2 (2017): 127-133.
Chicago
Götz, C., Montenarh, M."Protein kinase CK2 in development and differentiation (Review)". Biomedical Reports 6, no. 2 (2017): 127-133. https://doi.org/10.3892/br.2016.829
Copy and paste a formatted citation
x
Spandidos Publications style
Götz C and Montenarh M: Protein kinase CK2 in development and differentiation (Review). Biomed Rep 6: 127-133, 2017.
APA
Götz, C., & Montenarh, M. (2017). Protein kinase CK2 in development and differentiation (Review). Biomedical Reports, 6, 127-133. https://doi.org/10.3892/br.2016.829
MLA
Götz, C., Montenarh, M."Protein kinase CK2 in development and differentiation (Review)". Biomedical Reports 6.2 (2017): 127-133.
Chicago
Götz, C., Montenarh, M."Protein kinase CK2 in development and differentiation (Review)". Biomedical Reports 6, no. 2 (2017): 127-133. https://doi.org/10.3892/br.2016.829
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team